Bispecific Antibody and Chimeric Antigen Receptor (CAR) Modified T-cell in the Treatment of Multiple Myeloma: Where Do We Stand Today?
La Presse Médicale（2024）
Key words
Multiple myeloma,immunotherapy,bispecific antibody,CAR T-cell,therapy sequence,resistance mechanism
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined